Albemarle initiated with a Hold at Truist

Truist initiated coverage of Albemarle (ALB) with a Hold rating and $96 price target The firm believes Albemarle’s scale and relatively low-cost production footprint position the company well over the long term to capitalize on growth potential in the lithium market. However, the firm sees downside to consensus estimates for 2025 and 2026 and does not view the stock’s current valuation as compelling relative to Albemarle’s specialty chemical peers.